4//SEC Filing
Kaldor Stephen W 4
Accession 0001437749-13-006831
CIK 0001484478other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:54 PM ET
Size
9.3 KB
Accession
0001437749-13-006831
Insider Transaction Report
Form 4
Kaldor Stephen W
Director
Transactions
- Award
Common Stock
2013-05-24+3,580→ 3,580 total
Holdings
- 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 5,012
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (5,012 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying)
Footnotes (4)
- [F1]The restricted stock was awarded on 5/24/2013 and vests in its entirety on the earlier of 5/24/2014 or immediately prior to the 2014 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeother
Related Parties
1- filerCIK 0001507502
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:54 PM ET
- Size
- 9.3 KB